314 related articles for article (PubMed ID: 26765064)
21. Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy.
Choi YJ; Baek JH; Ha EJ; Lim HK; Lee JH; Kim JK; Song DE; Shong YK; Hong SJ
Thyroid; 2014 Mar; 24(3):494-501. PubMed ID: 23947771
[TBL] [Abstract][Full Text] [Related]
22. Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
Gan TR; Nga ME; Lum JH; Wong WM; Tan WB; Parameswaran R; Ngiam KY
Cancer Cytopathol; 2017 Apr; 125(4):245-256. PubMed ID: 28192631
[TBL] [Abstract][Full Text] [Related]
23. The impact of repeat fine-needle aspiration in thyroid nodules categorized as atypia of undetermined significance or follicular lesion of undetermined significance: A single center experience.
Marin F; Murillo R; Diego C; Jodar E; Acevedo A
Diagn Cytopathol; 2021 Mar; 49(3):412-417. PubMed ID: 33252841
[TBL] [Abstract][Full Text] [Related]
24. Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations.
Faquin WC; Baloch ZW
Diagn Cytopathol; 2010 Oct; 38(10):731-9. PubMed ID: 20049964
[TBL] [Abstract][Full Text] [Related]
25. Atypia of undetermined significance in thyroid fine-needle aspiration cytology: prediction of malignancy by US and comparison of methods for further management.
Lee KH; Shin JH; Oh YL; Hahn SY
Ann Surg Oncol; 2014 Jul; 21(7):2326-31. PubMed ID: 24566858
[TBL] [Abstract][Full Text] [Related]
26. Eliminating the "Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance" category from the Bethesda System for Reporting Thyroid Cytopathology.
Singh RS; Wang HH
Am J Clin Pathol; 2011 Dec; 136(6):896-902. PubMed ID: 22095375
[TBL] [Abstract][Full Text] [Related]
27. Core-needle biopsy versus repeat fine-needle aspiration for thyroid nodules initially read as atypia/follicular lesion of undetermined significance.
Choi YJ; Baek JH; Suh CH; Shim WH; Jeong B; Kim JK; Song DE; Kim TY; Chung KW; Lee JH
Head Neck; 2017 Feb; 39(2):361-369. PubMed ID: 27704650
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
Wong LQ; Baloch ZW
Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?
VanderLaan PA; Marqusee E; Krane JF
Am J Clin Pathol; 2011 May; 135(5):770-5. PubMed ID: 21502433
[TBL] [Abstract][Full Text] [Related]
30. Utility of subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance category in ultrasound-guided thyroid fine-needle aspiration in a large referral cancer center.
Gan Q; Edeiken BS; Chen MM; Grubbs EG; Busaidy NL; Zafereo M; Perrier ND; Gule-Monroe MD; Krishnamurthy S
J Am Soc Cytopathol; 2019; 8(6):309-316. PubMed ID: 31526696
[TBL] [Abstract][Full Text] [Related]
31. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
[TBL] [Abstract][Full Text] [Related]
32. The Bethesda system for reporting thyroid cytopathology: an institutional experience of the outcome of indeterminate categories.
Onder S; Firat P; Ates D
Cytopathology; 2014 Jun; 25(3):177-84. PubMed ID: 23998291
[TBL] [Abstract][Full Text] [Related]
33. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
[TBL] [Abstract][Full Text] [Related]
34. Cytological Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma before and after the Bethesda System for Reporting Thyroid Cytopathology.
Fazeli R; VandenBussche CJ; Bishop JA; Ali SZ
Acta Cytol; 2016; 60(1):14-8. PubMed ID: 27007511
[TBL] [Abstract][Full Text] [Related]
35. Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.
Lim JXY; Nga ME; Chan DKH; Tan WB; Parameswaran R; Ngiam KY
Thyroid; 2018 Apr; 28(4):511-521. PubMed ID: 29596039
[TBL] [Abstract][Full Text] [Related]
36. The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the rate of malignancy for atypia of undetermined significance subcategories.
Hang JF; Westra WH; Zhou AG; Cooper DS; Ali SZ
Cancer Cytopathol; 2018 May; 126(5):309-316. PubMed ID: 29424960
[TBL] [Abstract][Full Text] [Related]
37. Reclassification of cytologically atypical thyroid nodules based on radiologic features in pediatric patients.
Arva NC; Deitch SG
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):753-60. PubMed ID: 25879311
[TBL] [Abstract][Full Text] [Related]
38. Influence of descriptive terminology on management of atypical thyroid fine-needle aspirates.
Vivero M; Renshaw AA; Krane JF
Cancer Cytopathol; 2014 Mar; 122(3):175-81. PubMed ID: 24203313
[TBL] [Abstract][Full Text] [Related]
39. Adequacy criteria for thyroid FNA evaluated by ThinPrep slides only.
Vivero M; Renshaw AA; Krane JF
Cancer Cytopathol; 2017 Jul; 125(7):534-543. PubMed ID: 28388017
[TBL] [Abstract][Full Text] [Related]
40. Combining molecular testing and the Bethesda category III:VI ratio for thyroid fine-needle aspirates: A quality-assurance metric for evaluating diagnostic performance in a cytopathology laboratory.
Gokozan HN; Dilcher TL; Alperstein SA; Qiu Y; Mostyka M; Scognamiglio T; Solomon JP; Song W; Rennert H; Beg S; Stern E; Goyal A; Siddiqui MT; Heymann JJ
Cancer Cytopathol; 2022 Apr; 130(4):259-274. PubMed ID: 34962713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
